does glp-1 cause thyroid cancer Glucagon-like peptide 1 receptor agonist use and risk of cancer: Scandinavian cohort study The Thyroid Twist: How GLP-1

Fatima Cody Stanford, an obesity medicine physician at Massachusetts General Hospital in Boston and an associate professor of medicine and pediatrics at Harvard Medical School

We do not know how long someone should stay on the medication, or whether the craving reduction persists after stopping

However, this reduction has progressed in parallel among groups of patients with and without diabetes, and the gap in CVD risk between individuals with and without diabetes is unchanged [63]

It involves hormones, appetite signaling, insulin response, inflammation, liver metabolism, sleep, stress, genetics, medications, and environment